Email
Website
Sector
Tags
KANDO id: 6868704
Company type
Biotech - Cannabis R&D. We are a US DEA licensed manufacturer of Schedule 1 drugs.Overview
Maridose in collaboration with Israel’s medical marijuana pioneer Tikun-Olam has been approved by the US Drug Enforcement Administration (DEA) to be a Schedule 1 drug manufacturer licensed to cultivate marijuana for research and commercial product development purposes. Our research/cultivation facility and Center of Excellence for Cannabis Research is located at Brunswick Landing in Brunswick, Maine. Unlike the approximately 600 Schedule 1 cannabis “researchers”, our license allows us to legally research the live plant.
Funding rounds
Investment activity status
Active investor